Tagged: BioTek

BioTek and Chaitanya Gadde, its CEO, Agreed to Pay $20 Million, and Dr. David Tabby, Agreed to Pay $480K to Resolve Anti-Kickback Violations

BioTek and Chaitanya Gadde, its CEO, Agreed to Pay $20 Million, and Dr. David Tabby, Agreed to Pay $480K to Resolve Anti-Kickback Violations

The reach of the Anti-Kickback Statute and the False Claims Act is broad.  As a result, AKS liability is a real and significant risk for healthcare companies and providers. Healthcare companies and providers have to resolve such claims because of the potential consequence of exclusion from “federal health care programs,” which is essentially a death sentence for any covered company that received federal reimbursement. In...